Scopia Surgical closes its 2,65M$ oversubscribed preseed round

September 1st, 2026

The round was co-led by Linearis Ventures and Anges Québec with participation from HaloHealth, Richard Rubin, Suresh Madan, Investissement Québec, and other notable investors. The proceeds will be used to complete our first in human, achieve regulatory milestones and begin early commercialization.